BRPI0711924A8 - processo para a preparação de cefadroxil em forma de cristal, cefadroxil em forma de cristal e composição farmacêutica - Google Patents

processo para a preparação de cefadroxil em forma de cristal, cefadroxil em forma de cristal e composição farmacêutica

Info

Publication number
BRPI0711924A8
BRPI0711924A8 BRPI0711924A BRPI0711924A BRPI0711924A8 BR PI0711924 A8 BRPI0711924 A8 BR PI0711924A8 BR PI0711924 A BRPI0711924 A BR PI0711924A BR PI0711924 A BRPI0711924 A BR PI0711924A BR PI0711924 A8 BRPI0711924 A8 BR PI0711924A8
Authority
BR
Brazil
Prior art keywords
cefadroxil
crystal form
preparation
pharmaceutical composition
crystallization vessel
Prior art date
Application number
BRPI0711924A
Other languages
English (en)
Inventor
Enrique Lenhardt Carlos
Monro Moody Harold
Johannes Godfried Maria Van Dooren Theodorus
Original Assignee
Dsm Ip Assets Bv
Dsm Sinochem Pharm Nl Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv, Dsm Sinochem Pharm Nl Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0711924A2 publication Critical patent/BRPI0711924A2/pt
Publication of BRPI0711924A8 publication Critical patent/BRPI0711924A8/pt
Publication of BRPI0711924B1 publication Critical patent/BRPI0711924B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

processo para a preparação de cefadroxil em forma de cristal, cefadroxil em forma de cristal e composição farmacêutica. a presente invenção refere-se a um processo para a preparação de cefadroxil em forma de cristal, compreendendo a) adicionar uma solução aquosa de cefadroxil a um recipiente de cristalização e um titulante para manter um ph no recipiente de cristalização entre 7 e 9; e b) diminuir o ph no recipiente de cristalização a um valor entre 5 e 6,5 para obter uma suspensão do composto de <225>-lactama em forma de cristal. a invenção refere-se ainda a cefadroxil em forma de cristal obtenível pelo processo de acordo com a presente invenção. a invenção também se refere a cefadroxil em forma de cristal com um valor de cie b abaixo de 12 quando armazenado em uma temperatura de 25<198>c por pelo menos 1 mês.
BRPI0711924-0A 2006-05-19 2007-05-11 Processo para a preparação de cefadroxil monoidratado em forma de cristal BRPI0711924B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114240 2006-05-19
EP06114240.2 2006-05-19
PCT/EP2007/054572 WO2007134987A1 (en) 2006-05-19 2007-05-11 Process for the crystallisation of cefadroxil

Publications (3)

Publication Number Publication Date
BRPI0711924A2 BRPI0711924A2 (pt) 2012-02-22
BRPI0711924A8 true BRPI0711924A8 (pt) 2018-12-11
BRPI0711924B1 BRPI0711924B1 (pt) 2023-11-28

Family

ID=37309255

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0711924-0A BRPI0711924B1 (pt) 2006-05-19 2007-05-11 Processo para a preparação de cefadroxil monoidratado em forma de cristal

Country Status (10)

Country Link
US (2) US8420806B2 (pt)
EP (2) EP2754663B1 (pt)
JP (1) JP2009537589A (pt)
KR (1) KR101420451B1 (pt)
CN (2) CN101448842A (pt)
BR (1) BRPI0711924B1 (pt)
ES (1) ES2609633T3 (pt)
HK (1) HK1199447A1 (pt)
MX (1) MX2008014711A (pt)
WO (1) WO2007134987A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102134250B (zh) * 2011-01-19 2013-03-13 天津大学 一种头孢羟氨苄单水合物的结晶方法及结晶
CN102268019B (zh) * 2011-07-15 2013-07-10 海南美大制药有限公司 一种头孢羟氨苄化合物及其制法
CN104447795B (zh) * 2014-11-28 2016-08-17 珠海金鸿药业股份有限公司 一种头孢羟氨苄化合物及其药物组合物
CN105534937B (zh) * 2015-12-30 2019-12-03 石药集团欧意药业有限公司 一种头孢羟氨苄片剂及其制备方法
CN106588954B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物羟氨苄晶体化合物及其组合物
CN106588953B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物头孢羟氨苄晶型化合物及其组合物
KR102575537B1 (ko) * 2017-05-26 2023-09-07 코르테바 애그리사이언스 엘엘씨 피라졸 아민 반응성 결정화

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489752A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
US3781282A (en) * 1971-01-20 1973-12-25 W Garbrecht Cephalosporin process and product
US3985741A (en) * 1972-09-15 1976-10-12 Bristol-Myers Company Production of p-hydroxycephalexin
US4091215A (en) * 1974-06-05 1978-05-23 Bristol-Myers Company 7-D-α-Amino-.alpha.-(p-acetoxyphenyl)acetamido-3-methyl-3-cephem-4-carboxylic acid
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
US4223135A (en) * 1979-03-19 1980-09-16 Bristol-Myers Company Production of cephalosporins
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
US4904776A (en) * 1987-04-24 1990-02-27 Rifar S.R.L. Method for producing crystalline cefadroxil hemihydrate
US4898938A (en) * 1987-08-03 1990-02-06 Rifar S.R.L. Method for preparing crystalline cefadroxil monohydrate
ES2010288A6 (es) * 1988-07-08 1989-11-01 Gema Sa Procedimiento para la obtencion de un pseudopolimorfo de cefadroxilo.
GB2240102B (en) * 1990-01-22 1993-10-20 Biochemie Gmbh Improvements in or relating to beta lactam production
DE69133509T2 (de) 1990-07-04 2006-08-24 Dsm Ip Assets B.V. Verfahren zur herstellung von beta-lactamen
AU3163295A (en) 1994-07-18 1996-02-16 Gist-Brocades B.V. Process for preparation of beta -lactams at constantly high concentration of reactants
DE69626842D1 (de) 1995-12-08 2003-04-24 Dsm Nv Verfahren zur herstellung eines anitibiotkums
NL1007302C2 (nl) 1997-10-17 1999-04-20 Dsm Nv Werkwijze voor de bereiding van een ß-lactam antibioticum.
AU1234999A (en) 1997-11-10 1999-05-31 Gist-Brocades B.V. Crystallization of beta-lactam compounds
PE20000879A1 (es) * 1998-04-29 2000-09-23 Dsm Nv METODO PARA CRISTALIZAR UN ANTIBIOTICO ß-LACTAMICO
US20040077849A1 (en) * 2002-10-16 2004-04-22 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefadroxil
US8420846B2 (en) * 2008-08-25 2013-04-16 Jubilant Life Sciences Limited Process for producing (S)-3-[(1-dimethylamino)ethyl] phenyl-N-ethyl-N-methyl-carbamate via novel intermediates

Also Published As

Publication number Publication date
MX2008014711A (es) 2008-12-03
US20100010213A1 (en) 2010-01-14
EP2754663A1 (en) 2014-07-16
CN101448842A (zh) 2009-06-03
KR20090010065A (ko) 2009-01-28
BRPI0711924A2 (pt) 2012-02-22
EP2754663B1 (en) 2016-10-12
CN102351884A (zh) 2012-02-15
JP2009537589A (ja) 2009-10-29
ES2609633T3 (es) 2017-04-21
KR101420451B1 (ko) 2014-07-16
US8420806B2 (en) 2013-04-16
BRPI0711924B1 (pt) 2023-11-28
HK1199447A1 (en) 2015-07-03
US20130217659A1 (en) 2013-08-22
CN102351884B (zh) 2015-06-17
EP2024374A1 (en) 2009-02-18
WO2007134987A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
BRPI0711924A8 (pt) processo para a preparação de cefadroxil em forma de cristal, cefadroxil em forma de cristal e composição farmacêutica
MX347257B (es) Solido de gamma-carbolinas fusionadas con heterociclos substituidos.
AR066130A1 (es) Formas cristalinas de saxagliptina y procesos para preparar las mismas
WO2009080203A3 (en) Aminobenzamide derivatives as useful agents for controlling animal parasites
WO2007089768A3 (en) 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
BRPI0612957B8 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
CY1109072T1 (el) Βητα κρυσταλλικη μορφη του υδροχλωρικου αλατος της ιβαμπραδινης, μεθοδος παρασκευης αυτου και φαρμακευτικης συνθεσεις που το περιεχουν
UA92761C2 (ru) Кристаллы лаквинимода натрия и способ их изготовления
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
CU20060038A7 (es) Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
DE602008002820D1 (de) Hydrogensulfat von 2-Acetoxy-5-(a-cyclopropylcarbonyl-2-fluorbenzyl)-4,5,6,7-tetrahydrothienoÄ3,2-cÜpyridin und dessen Zubereitung
MY150778A (en) Fused heterocyclic compound
TW200631580A (en) Substituted benzoquinolizine derivatives
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
BR112012014721A2 (pt) composição de hormônio do crescimento
IL227565A (en) Salts of hexahydropananthridine preserved in position 5 of the heterocyclic group and pharmaceutical preparations containing them
WO2008080891A3 (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
CO6720965A2 (es) Monohidrato de derivados de aza-adamantano
MX2020005564A (es) Sales de 4-amino-n-(1-((3-cloro-2-fluorofnil)amino)-6-metilisoquin olin-5-il)tieno[3,2-d]pirimidino-7-carboxamida, y formas cristalinas de las mismas.
WO2006129160A3 (en) Stable aqueous oral solution of risperidone
EA201001870A1 (ru) Новые кристаллические формы рабепразола натрия
BR112013032901A2 (pt) processo para fabricação de derivados de hidroxietilamido
UA101654C2 (uk) Матриксна фармацевтична композиція на основі гідросульфату (2-гідроксіетоксі)аміду 6-(4-бром-2-хлорфеніламіно)-7-фтор-3-метил-3н-бензоімідазол-5-карбонової кислоти
WO2010013835A3 (en) Solid pharmaceutical composition
BRPI0509506A (pt) forma cristalina de pirazóis, processo para a conversão da mesma, compisição farmacêutica, uso, processo para tornar a forma cristalina e processo para a produção da referida forma

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V. (NL)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. (NL)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/05/2007, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.